Patent · US Active

Method of treating retinitis pigmentosa

US8961993B2 · kind B2 · utility

0Cited by
3References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 18, 2013
Grant dateFeb 24, 2015
Priority date
Expiry dateJul 18, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.